New Zealand - English - Medsafe (Medicines Safety Authority)

asta medica australasia pty (nz) limited - cyclophosphamide monohydrate 200mg - powder for injection - 200 mg - active: cyclophosphamide monohydrate 200mg

New Zealand - English - Medsafe (Medicines Safety Authority)

asta medica australasia pty (nz) limited - cyclophosphamide monohydrate 500mg - powder for injection - 500 mg - active: cyclophosphamide monohydrate 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

hospira nz ltd - methotrexate 25 mg/ml;   - solution for injection - 100 mg/4ml - active: methotrexate 25 mg/ml   excipient: sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 2.5mg;   - tablet - 2.5 mg - active: methotrexate 2.5mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 80 starch - for the treatment of breast cancer

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - diltiazem hydrochloride 120mg - modified release capsule - 120 mg - active: diltiazem hydrochloride 120mg excipient: ethylcellulose   hydrated silica   hydrogenated castor oil hypromellose   iron oxide yellow magnesium stearate   mannitol starch

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - diltiazem hydrochloride 180mg - modified release capsule - 180 mg - active: diltiazem hydrochloride 180mg excipient: ethylcellulose   hydrated silica   hydrogenated castor oil hypromellose   iron oxide yellow magnesium stearate   mannitol

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - diltiazem hydrochloride 240mg - modified release capsule - 240 mg - active: diltiazem hydrochloride 240mg excipient: colloidal hydrated silica ethylcellulose   hydrated silica hydrogenated castor oil hypromellose   iron oxide yellow magnesium stearate   mannitol

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - methotrexate 20 mg/ml - injection with diluent - 20 mg/ml - active: methotrexate 20 mg/ml excipient: sodium chloride sodium hydroxide water for injection - - active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (dmards) is indicated. - polyarthritic forms of severe, active juvenile idiopathic arthritis (jia) when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate - severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, puva, and retinoids, and severe psoriatic arthritis.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - toremifene citrate 88.5mg equivalent to 60 mg toremifene - tablet - 60 mg - active: toremifene citrate 88.5mg equivalent to 60 mg toremifene excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - flutamide 250mg;   - tablet - 250 mg - active: flutamide 250mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified water sodium laurilsulfate - for the palliative treatment of advanced prostatic cancer in previously untreated patients or those who have not responded or who have become refractory to hormonal manipulation. as a component of the treatment used in the management of locally advanced prostatic carcinoma.